MERCK SHARP DOHME COMERCIALIZADORA Q1-2026 supplier risk profile and import data analysis.
MERCK SHARP DOHME COMERCIALIZADORA imported 725 shipments across 25 suppliers in Q1 2026, sourcing from 8 countries with dominant US presence at 80% of volume. PPD CENTRAL LABS led supplier activity with 215 shipments, followed by Q SQUARED SOLUTIONS with 118 shipments. The import profile centers on HS Chapter 98 (Special Classification Provisions) at 21% of shipments, alongside significant activity in HS Chapter 90 (Optical and Medical Instruments).
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer recorded zero matches against sanctions watchlists in Q1 2026. No suppliers in the sourcing network registered exposure to forced-labor proximity flags under the Uyghur Forced Labor Prevention Act framework.
25 distinct tier-1 suppliers in Q1 2026
| PPD CENTRAL LABS | United States | 215 |
| Q SQUARED SOLUTIONS | United States | 118 |
| ALMAC CLINICAL SERVICES | United Kingdom | 68 |
| LABCORP CENTRAL LABORATORY SERVICES | United States | 67 |
| MERCK SHARP DOHME | United States | 53 |
| ALMAC CLINICAL SERVICES | United States | 36 |
| FISHER CLINICAL SERVICES | United States | 35 |
| WERTHENSTEIN BIOPHARMA | Switzerland | 28 |
Share of Q1 2026 inbound shipments by source country
0 tier-2 + 0 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.